BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33634017)

  • 1. The Role of Interleukin-33 in Head and Neck Squamous Cell Carcinoma Is Determined by Its Cellular Sources in the Tumor Microenvironment.
    Peng L; Sun W; Chen L; Wen WP
    Front Oncol; 2020; 10():588454. PubMed ID: 33634017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
    Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
    Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
    Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
    Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene Expression Subtype Predicts Nodal Metastasis and Survival in Human Papillomavirus-Negative Head and Neck Cancer.
    Zevallos JP; Mazul AL; Walter V; Hayes DN
    Laryngoscope; 2019 Jan; 129(1):154-161. PubMed ID: 30247749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in tumor mutation burden between squamous cell carcinoma in the oral cavity and larynx.
    Cui J; Wang D; Nie D; Liu W; Sun M; Pei F; Han F
    Oral Oncol; 2021 Mar; 114():105142. PubMed ID: 33465682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
    Van Tubergen E; Vander Broek R; Lee J; Wolf G; Carey T; Bradford C; Prince M; Kirkwood KL; D'Silva NJ
    Cancer; 2011 Jun; 117(12):2677-89. PubMed ID: 21656745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical significance of apolipoprotein L1 in head and neck squamous cell carcinoma.
    Zhong F; Lu HP; Chen G; Dang YW; Zhang XG; Liang Y; Li MX; Li GS; Chen XY; Yao YX; Qin YY; Mo M; Zhang KL; Ding H; Huang ZG; Wei ZX
    Oncol Lett; 2020 Dec; 20(6):377. PubMed ID: 33154775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis.
    Wen YH; Lin HQ; Li H; Zhao Y; Lui VWY; Chen L; Wu XM; Sun W; Wen WP
    Cancer Immunol Immunother; 2019 Feb; 68(2):221-232. PubMed ID: 30357458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
    Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
    J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
    Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
    St John MA
    Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 alpha increases anti-tumor efficacy of cetuximab in head and neck squamous cell carcinoma.
    Espinosa-Cotton M; Rodman Iii SN; Ross KA; Jensen IJ; Sangodeyi-Miller K; McLaren AJ; Dahl RA; Gibson-Corley KN; Koch AT; Fu YX; Badovinac VP; Laux D; Narasimhan B; Simons AL
    J Immunother Cancer; 2019 Mar; 7(1):79. PubMed ID: 30890189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-8 as a modulator of response to bevacizumab in preclinical models of head and neck squamous cell carcinoma.
    Gyanchandani R; Sano D; Ortega Alves MV; Klein JD; Knapick BA; Oh S; Myers JN; Kim S
    Oral Oncol; 2013 Aug; 49(8):761-70. PubMed ID: 23623402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognosis of head and neck squamous cell carcinoma related to immunosuppressive tumor microenvironment regulated by IL-6 signaling.
    Tsai MS; Chen WC; Lu CH; Chen MF
    Oral Oncol; 2019 Apr; 91():47-55. PubMed ID: 30926062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way.
    Peng L; Sun W; Wei F; Chen L; Wen W
    Aging (Albany NY); 2021 Feb; 13(5):6740-6751. PubMed ID: 33621202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FGFR Family Members Protein Expression as Prognostic Markers in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Koole K; Clausen MJ; van Es RJ; van Kempen PM; Melchers LJ; Koole R; Langendijk JA; van Diest PJ; Roodenburg JL; Schuuring E; Willems SM
    Mol Diagn Ther; 2016 Aug; 20(4):363-74. PubMed ID: 27278367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer.
    Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y
    Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791
    [No Abstract]   [Full Text] [Related]  

  • 19. Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma.
    Suzuki S; Toyoma S; Kawasaki Y; Yamada T
    PLoS One; 2022; 17(1):e0262549. PubMed ID: 35089951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.